Sampre Nutritions Ltd is Rated Sell

1 hour ago
share
Share Via
Sampre Nutritions Ltd is rated 'Sell' by MarketsMojo, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 September 2026, providing investors with an up-to-date perspective on the company’s performance and outlook.
Sampre Nutritions Ltd is Rated Sell

Understanding the Current Rating

The 'Sell' rating assigned to Sampre Nutritions Ltd indicates a cautious stance for investors, suggesting that the stock may underperform relative to the broader market or its sector peers. This recommendation is based on a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential as of today.

Quality Assessment

Currently, Sampre Nutritions Ltd holds a below average quality grade. This reflects concerns about the company’s fundamental strength and operational efficiency. As of 18 September 2026, the company’s average Return on Capital Employed (ROCE) stands at a modest 1.28%, signalling limited effectiveness in generating profits from its capital base. Furthermore, operating profit growth over the past five years has averaged 14.75% annually, which, while positive, is not sufficiently robust to inspire confidence in sustained long-term growth.

Another critical aspect of quality is the company’s ability to service its debt. Sampre Nutritions Ltd exhibits a weak EBIT to Interest coverage ratio of 0.45 on average, indicating that earnings before interest and taxes are less than half of the interest obligations. This raises concerns about financial stability and the risk of liquidity pressures, which investors should carefully consider.

Valuation Perspective

Despite the challenges in quality, the stock’s valuation grade is currently very attractive. This suggests that Sampre Nutritions Ltd is trading at a price level that may offer value relative to its earnings, assets, or cash flows. For value-oriented investors, this could present an opportunity to acquire shares at a discount compared to intrinsic worth or sector benchmarks. However, attractive valuation alone does not guarantee positive returns, especially if underlying fundamentals remain weak.

Financial Trend Analysis

The financial grade for Sampre Nutritions Ltd is positive, indicating some favourable trends in recent financial performance. However, this must be viewed in the context of the stock’s overall returns and market behaviour. As of 18 September 2026, the stock has delivered a disappointing -76.48% return over the past year, reflecting significant erosion of shareholder value. The year-to-date return is similarly negative at -75.52%, and the six-month return shows a steep decline of -73.17%.

These figures highlight persistent challenges in the company’s operational and market performance. Additionally, the stock has underperformed the BSE500 index over the last three years, one year, and three months, signalling that it has lagged behind broader market gains and sector peers.

Technical Outlook

From a technical standpoint, Sampre Nutritions Ltd is rated mildly bearish. This suggests that recent price movements and chart patterns indicate downward momentum or limited upside potential in the near term. The stock’s one-day gain of 1.00% and one-month gain of 8.94% offer some short-term relief, but these are overshadowed by longer-term negative trends, including a three-month decline of -28.60% and a one-week loss of -1.62%.

Technical analysis complements fundamental insights by providing a market sentiment gauge, which currently advises caution for investors considering new positions or holding existing shares.

Summary of Current Position

In summary, Sampre Nutritions Ltd’s 'Sell' rating reflects a balanced view of its current investment profile. While the stock is attractively valued and shows some positive financial trends, the below average quality and bearish technical signals, combined with substantial negative returns, suggest that investors should approach with caution. The company’s weak debt servicing ability and modest profitability metrics further underline the risks involved.

Investors should weigh these factors carefully, considering their own risk tolerance and investment horizon before making decisions related to Sampre Nutritions Ltd.

Our current monthly pick, this Mid Cap from Automobile Two & Three Wheelers, survived rigorous evaluation against dozens of contenders. See why experts are backing this one!

  • - Rigorous evaluation cleared
  • - Expert-backed selection
  • - Mid Cap conviction pick

See Expert Backing →

Contextualising the Stock’s Market Performance

It is important to place Sampre Nutritions Ltd’s performance within the broader market and sector context. The FMCG sector, known for its resilience and steady growth, has generally outperformed many other sectors in recent years. However, Sampre Nutritions Ltd’s microcap status and operational challenges have limited its ability to capitalise on sector tailwinds.

The stock’s significant underperformance relative to the BSE500 index over multiple time frames highlights the divergence from market leaders and sector benchmarks. This underperformance may be attributed to company-specific issues such as weak profitability, debt servicing concerns, and inconsistent growth.

Investor Implications and Considerations

For investors, the 'Sell' rating serves as a cautionary signal. It suggests that the stock may not be suitable for those seeking capital appreciation or stable returns in the near to medium term. The combination of weak quality metrics and bearish technical indicators implies elevated risk, particularly for risk-averse or income-focused investors.

However, the very attractive valuation grade indicates that the stock could be of interest to value investors willing to accept higher risk in anticipation of a potential turnaround or re-rating. Such investors should conduct thorough due diligence and monitor the company’s financial health and market developments closely.

Ultimately, the current rating and analysis provide a comprehensive framework for understanding Sampre Nutritions Ltd’s investment profile as of 18 September 2026, enabling informed decision-making based on up-to-date data.

Looking Ahead

Going forward, key factors to watch include improvements in operating profit growth, enhanced debt servicing capacity, and shifts in market sentiment reflected in technical indicators. Any positive developments in these areas could influence future ratings and investor confidence.

Until such changes materialise, the 'Sell' rating remains a prudent reflection of the company’s current challenges and market position.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Sampre Nutritions Ltd is Rated Sell
Sep 04 2026 10:10 AM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Aug 19 2026 10:11 AM IST
share
Share Via
Are Sampre Nutritions Ltd latest results good or bad?
Aug 05 2026 07:24 PM IST
share
Share Via
Sampre Nutritions Ltd is Rated Sell
Aug 05 2026 10:10 AM IST
share
Share Via